Pharma Marketing Blog talks about Rozerem’s big marketing push, and wonders how such ludicrous displays passes FDA regulation:
BTW, how are little promos like this on medical conference sites sponsored by CME providers like M|C Communications — host of the Pri-Med Conference — regulated by the FDA? For example, the benefit statement above is not balanced by risk information, nor is there any link on this page to the package insert or to the Rozerem Web site where the physician can see the PI.Perhaps M|C Communications will claim that they wrote the promo, not Takeda and the FDA has no jurisdiction over what it can say. Yeah, right!
Related posts:
- Those stupid Rozerem ads
- Rozerem: Marketing costs exceeds revenues
- Pfizer’s Adwords run afoul of FDA regulations
- More stupid Rozerem ads
- Multiple sclerosis simulator: A marketing ploy?
- Newsflash: Sleeping medications are being overprescribed
- Subliminal pharma marketing on Scrubs
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe





Comments on this entry are closed.